Latest News

Intervention to help GPs identify and treat patients with hepatitis C found to be effective

The first UK clinical trial to increase the identification and treatment of hepatitis C (HCV) patients in primary care has been found to be effective, acceptable to staff and highly cost-effective for the NHS. The University of Bristol-led Hepatitis C Assessment to Treatment Trial (HepCATT), published in the British Medical Journal today, provides robust evidence of effective action GPs should take to increase HCV testing and treatment.

Source link

Related posts

STAT Plus: Did a biotech exec crib a New Yorker cartoon?


STAT Plus: How do you improve Medicare? Maybe you watch Major League Baseball


MIT engineers devise new way to create nanoemulsions


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy